Oculis Share Price

Oculis Share Price

NASDAQ: OCS | Healthcare
$7.06
-$0.39 (-5.17%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Oculis Stock Performance

Open
$7.30
Prev. Close
$7.45
Circuit Range
N/A
Day Range
$7.01 - $7.30
Year Range
$6.81 - $34.13
Volume
11,332
Average Traded
$7.09

Oculis Share Price Today

As of 21 November 2026, Oculis Holding AG's share price is $7.06. The stock opened at $7.30, compared to its previous close of $7.45. During today's trading session, Oculis Holding AG's share price traded between $7.01 and $7.30, with an average price of $7.16. Over the past 52 weeks, the stock has recorded a high of $34.13 and a low of $6.81. In terms of performance, Oculis Holding AG's share price has declined by 68.61% over the last six months and is down 62.82% on a year-on-year basis.

Oculis Share Price Chart

Line chart of the Oculis price trend over the selected period. The price fell overall, ranging from 6.97 to 7.37, ending at 7.06.
$7.01$7.30
L
Show Current Price
H

Oculis Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Oculis Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$105.59-$94.96-$124.70
Net Profit MarginN/AN/AN/A
Income ChangeN/A10.07%-31.32%

Oculis Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets21.5217.1115.86
Current Assets275.83116.13120.11
Total Assets297.35133.24135.97
Non Current Liabilities3.963.031.83
Current Liabilities46.3148.9722.7
Total Liabilities50.2752.024.52
Shareholders' Equity247.0781.24111.45

Oculis Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-83.55-54.16-65.44
Investing-76.79-17.8-62.99
Financing235.5459.75154.13

About Oculis

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Oculis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$8.17
$7.05
-14.65%
Oct 2026
$8.95
$8.26
-11.47%
Sep 2026
$12.18
$9.33
-25.15%
Aug 2026
$11.97
$12.46
+10.11%
Jul 2026
$13.73
$11.32
-18.27%
Jun 2026
$15.86
$13.85
-38.42%
May 2026
$27.36
$22.49
-17.95%
Apr 2026
$26.66
$27.41
+3.12%
Mar 2026
$28.81
$26.58
-9.35%
Feb 2026
$28.61
$29.32
+3.13%
Jan 2026
$19.85
$28.43
+42.43%
Dec 2025
$19.08
$19.96
+5.11%

Oculis Share Price FAQs